Trends Shaping Global Drug Development
Discover the latest trends in global drug development, from personalized medicine and CRO growth to AI, mRNA vaccines, biosimilars, and innovative clinical trial models shaping the future of healthcare.
Developing a drug takes a minimum of 12 to 18 years and more than $1 billion to produce a medicine from preclinical research to launch. Pfizer, Novartis, Johnson & Johnson, Roche, and Merck & Co. are the top pharmaceutical companies in the world according to predicted R&D investment in 2026.
Revenue-wise, the worldwide CRO services market is expected to reach $127.3 billion by 2028 from its anticipated $76.6 billion in 2023. IQVIA, Labcorp, Parexel, ICON, and Syneos Health are the leading companies in the Contract Research Organization (CRO) services market.
The field of drug development has changed over time. Major pharmaceutical corporations have historically prioritized internally produced blockbuster medications. The current trend is toward a more inclusive, patient-centered paradigm.
A successful drug has necessarily passed through five main stages that include:
- Drug Discovery and development
- Pre-clinical research
- Clinical trials
- Regulatory approval
- Post-market monitoring
Clinical Research
The field of clinical research in healthcare science evaluates the safety and efficacy of drugs, technologies, diagnostic tools, and treatment plans meant for human consumption. These can be applied to disease diagnosis, treatment, prevention, or symptom relief. Clinical practice and clinical research are not the same thing. Clinical research gathers evidence to establish a treatment,…
Create an account to continue reading
Create AccountAlready have an account? Sign in
Need an expert in this space?
Talk to an Industry Expert
Knowledge Ridge connects decision-makers with carefully vetted subject matter experts for one-on-one calls, research sprints, and advisory engagements — across 11 sectors and 163 sub-industries globally.
Comments
No comments yet. Be the first to comment!